Sindrom razdrazhennogo kishechnika s pozitsiy sovremennoy gastroenterologii


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Irritable Bowel Syndrome (IBS) - is a widespread functional disorder clinically characterized by abdominal pain and violation of the bowel evacuation. The article presents the current data on the epidemiological structure of IBS. Potential mechanisms for the genesis of this disease are discussed. Diagnostic criteria and relevant non-drug and pharmacological treatments for IBS are considered.

全文:

受限制的访问

参考

  1. Soares R.L. Irritable bowel syndrome: A clinical review. World J. Gastroenterol. 2014;20(34):12144-60.
  2. Occhipinti K., Smith J.W. Irritable bowel syndrome: a review and update. Clin. Colon Rectal. Surg. 2012;25:46-52.
  3. Everhart J.E., Renault P.F. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology. 1991;100:998-1005.
  4. Talley N.J. Irritable bowel syndrome. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2010. 118 p.
  5. Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014;6:71-80.
  6. Lovell R.M., Ford A.C. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin. Gastroenterol. Hepatol. 2012;10(7):712-21.
  7. Маев И.В., Дичева Д.Т., Андреев Д.Н., Сенина Ю.С. Синдром раздраженного кишечника в практике гастроэнтеролога. Актуальные вопросы ведомственной медицины. Сборник научных трудов. М., 2012. С. 83-8.
  8. Husain N., Chaudhry I.B., Jafri F., et al. A population-based study of irritable bowel syndrome in a non-Western population. Neurogastroenterol. Motil. 2008;20(9):1022-29.
  9. Drossman D.A. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology. 2006;130(5):1377-90.
  10. Lee Y.J., Park K.S. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J. Gastroenterol. 2014;20(10):2456-69.
  11. Mayer E.A., Collins S.M. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology. 2002;122:2032-48.
  12. Маев И.В., Кучерявый Ю.А., Черемушкин С.В. Эволюция представлений о синдроме раздраженного кишечника. М., 2013.
  13. Saito Y.A. The role of genetics in IBS. Gastroenterol. Clin. North Am. 2011;40:45-67.
  14. Qin S.Y., Jiang H.X., Lu D.H., Zhou Y. Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis. World J. Gastroenterol. 2013;19(48):9472-80.
  15. Maynard C.L., Weaver C.T. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol. Rev. 2008;226:219-33.
  16. Halvorson H.A., Schlett C.D., Riddle M.S. Postinfectious irritable bowel syndrome - a meta-analysis. Am. J. Gastroenterol. 2006;101:1894-99.
  17. Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment. Pharmacol. Ther. 2007;26:535-44.
  18. Krogius-Kurikka L., Lyra A., Malinen E., et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009;9:95.
  19. Carroll I.M., Ringel-Kulka T., Keku T.O., et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 2011;301:G799-807.
  20. Dear K.L., Elia M., Hunter J.O. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome? Dig. Dis. Sci. 2005;50:758-66.
  21. Barbara G., De Giorgio R., Stanghellini V., et al. New pathophysiological mechanisms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 2004;20(Suppl 2):1-9.
  22. Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut. 2002;51:i67-71.
  23. Gunnarsson J., Simr n M. Peripheral factors in the pathophysiology of irritable bowel syndrome. Dig. Liver Dis. 2009;41:788-93.
  24. Bueno L., Fioramonti J., Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am. J. Physiol. Gastrointest. Liver Physiol. 2000;278: G670-6.
  25. Андреев Д.Н., Самсонов А.А., Черемушкин С.В. Синдром раздраженного кишечника: критерии диагностики и подходы к терапии. Фарматека. 2014;14:6-11.
  26. Гастроэнтерология. Национальное руководство: краткое издание/ Под. ред. В.Т. Ивашкина, Т.Л. Лапиной. М., 2011.
  27. Wilkins T., Pepitone C., Alex B., Schade R.R. Diagnosis and management of IBS in adults. Am. Fam. Physician. 2012;86(5):419-26.
  28. Riegler G., Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech. Coloproctol. 2001;5(3):163-4.
  29. Дичева Д.Т., Андреев Д.Н. Алгоритм диагностики и лечения синдрома раздраженного кишечника. Consilium Medicum. Гастроэнтерология. 2013;1:80.
  30. Owens D.M., Nelson D.K., Talley N.J. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann. Intern. Med. 1995;122:107-12.
  31. Hasler W.L., Owyang C. Irritable bowel syndrome. In: Textbook of Gastroenterology, 4th ed, Yamada T (Ed), JB Lippincott, Philadelphia, 2003. Р. 1817.
  32. Zhu Y., Zheng X., Cong Y., et al. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sen sation after lactose ingestion in a population with lactase deficiency. Am. J. Gastroenterol. 2013;108:1516-25.
  33. Shepherd S.J., Lomer M.C., Gibson P.R. Short-chain carbohydrates and functional gastrointestinal disorders. Am. J. Gastroenterol. 2013;108:707-17.
  34. Staudacher H.M., Irving P.M., Lomer M.C., Whelan K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat. Rev. Gastroenterol. Hepatol. 2014;11(4):256-66.
  35. Austin G.L., Dalton C.B., Hu Y., et al. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 2009;7:706-08.
  36. Halmos E.P., Power V.A., Shepherd S.J., et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146:67-75.
  37. Johannesson E., Simr n M., Strid H., et al. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am. J. Gastroenterol. 2011;106:915-22.
  38. Маев И.В., Дичева Д.Т., Андреев Д.Н., Сенина Ю.С. Применение миотропного спазмолитика Дицетел® в терапии синдрома раздраженного кишечника. Медицинский совет. 2012; 3:32-7.
  39. Маев И.В., Самсонов А.А., Андреев Д.Н. Современный алгоритм ведения пациентов с синдромом хронического запора с позиций внедрения новых фармакологических препаратов. Фарматека. 2012;13:37-43.
  40. Маев И., Дичева Д., Андреев Д. Новые возможности лечения хронического запора. Врач. 2012;3:45-8.
  41. Rahimi R., Abdollahi M. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. World J. Gastroenterol. 2012;18(7):589-600.
  42. Ottillinger B., Storr M., Malfertheiner P., Allescher H.D. STW 5 (Iberogast®) - a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med. Wochenschr. 2013;163(3-4):65-72.
  43. Krueger D., Gruber L., Buhner S., et al. The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine. Neurogastroenterol. Motil. 2009;21: 1203-110.
  44. Miller M.H., Liu C.Y., Glatzle J., et al. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine. Phytomedicine. 2006;13(Suppl 5):100-06.
  45. Madisch A., Holtmann G., Plein K. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment. Pharmacol. Ther. 2004;19(3):271-79.
  46. Klein-Galczinsky C., Sassin I. Anwendungsbeobachtung zur Wirksamkeit und Vertr glichkeit von Iberogast® in der Therapie des Colon irritabile. Phytotherapie an der Schwelle zum neuen Jahrtausend. 1999;125:Abstract P25.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##